NCT00277875View on ClinicalTrials.gov

STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISH

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

January 31, 2006

Conditions
Cardiovascular Disease
Interventions
DRUG

ALT-711 (alagebrium chloride)

Trial Locations (1)

21287

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Synvista Therapeutics, Inc

INDUSTRY

NCT00277875 - STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISH | Biotech Hunter | Biotech Hunter